Soleno Therapeutics Announces Presentations on VYKAT XR for Prader-Willi Syndrome at PES 2025

Soleno Therapeutics announced poster presentations on its VYKAT XR (diazoxide choline) extended-release tablets at the Pediatric Endocrine Society (PE...
Home/KnloSights/Clinical Trial Updates/Soleno Therapeutics Announces Presentations on VYKAT XR for Prader-Willi Syndrome at PES 2025